Approximately 80% of the PIK3CA mutations cluster within three hotspots in the coding sequence: E542K (~ 4% of human breast cancer) and E545K (~ 6%) within the helical domain; and H1047R (~ 15%) within the kinase domain of p110 α12–14. Here, PIK3CA is linked to breast carcinoma.